Effect of genetically engineered Salmonella typhimurium secreting conantokin G on PD-L1 antibody therapy and tumor regression in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility Molecular Instruments® (MI), the inventor of the HCR™ imaging platform, and ...
Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback